Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Clinical
Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in…
Clinical
Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Tablets for Oral…
FDA/EMA/Drug Designation
Ipsen, Enzyvant Hit with Setbacks from the FDA This Week
FDA/EMA/Drug Designation
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Medicare Costs for Seniors Lowered in Senate Drug-Price Bill …
Deals
Nicox signs agreement for ZERVIATE in South Korea
Commercial
Alexion Board Rejects Stakeholder Recommendation to Sell the Company
Deals
Idorsia and Mochida enter into a license agreement for the supply,…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Bristol-Myers Squibb and Acceleron Pharma Provide Update on FDA Advisory Committee for Reblozyl (luspatercept-aamt)
Firstwordpharma News
-
December 6, 2019
FDA/EMA/Drug Designation
Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks ...
FDA/EMA/Drug Designation
Janssen Announces BCMA CAR-T Therapy JNJ-4528 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Relapsed or Refractory Multiple Myeloma
FDA/EMA/Drug Designation
Ipsen, Enzyvant Hit with Setbacks from the FDA This Week
FDA/EMA/Drug Designation
Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
FDA/EMA/Drug Designation
Aurinia heads to FDA after voclosporin hits main goal of pivotal...
Firstwordpharma News
-
December 5, 2019
0
FDA/EMA/Drug Designation
Intellipharmaceutics Announces FDA Advisory Committee Meeting for Aximris XR (Oxycodone Hydrochloride...
Firstwordpharma News
-
December 5, 2019
0
FDA/EMA/Drug Designation
Adastra Pharmaceuticals Announces FDA and EMA Orphan Drug Designation Has Been...
Firstwordpharma News
-
December 4, 2019
0
FDA/EMA/Drug Designation
FDA Grants Orphan Drug Designation to APR Applied Pharma Research’s Investigational...
Firstwordpharma News
-
December 4, 2019
0
FDA/EMA/Drug Designation
Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma
Firstwordpharma News
-
December 4, 2019
0
1
2
3
...
27
Page 1 of 27
- Advertisement -
MOST POPULAR
Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug...
March 8, 2019
Oramed Patent Allowed in the U.S. for Oral Exenatide
April 4, 2019
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue...
November 23, 2019
SIIPL-PCV Vaccine Affordable, Effective, Safe for Immunising Children Against Pneumococcus: Presented...
May 13, 2019
Load more
HOT NEWS
Others
Aerpio Pharmaceuticals Presents Data Showing Potential of AKB-9778, a VE-PTP Inhibitor/Tie2...
Commercial
Clementia Announces Pricing of Public Offering of Common Shares
Immuno-oncology
Genetic Mutations Predict Response to Apatinib in Young Patients With Sarcoma:...
Phase I
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar,...
